文献速递白血病

SETD1B催化结构域调控MLL重排白血病中H3K4me3宽度与MYC表达

Regulation of H3K4me3 breadth and MYC expression by the SETD1B catalytic domain in MLL-rearranged leukemia.
PubMed 文献 · Leukemia · 2025-05-08

本研究在MLL重排急性髓系白血病模型中开展CRISPR覆盖筛选,鉴定H3K4me3修饰相关酶,发现破坏SETD1B催化SET结构域可导致FLT3-ITD或NrasG12D表达的白血病细胞耗竭及MYC通路基因表达下调。SETD1B SET结构域缺失显著降低H3K4me3宽度,外源性MYC表达或破坏H3K4去甲基化酶KDM5C可显著恢复SETD1B SET结构域突变细胞的生长缺陷。

要点

  • 在MLL重排AML模型中,破坏SETD1B催化SET结构域导致FLT3-ITD或NrasG12D表达的白血病细胞耗竭。
  • SETD1B SET结构域缺失显著降低H3K4me3宽度,并下调MYC通路基因表达。
  • 外源性MYC表达或破坏KDM5C可显著恢复SETD1B SET结构域突变细胞的生长缺陷。

核心结论

  • SETD1B为H3K4me3宽度和MYC表达所必需,深入理解SETD1B介导的H3K4me3宽度对开发MYC依赖性白血病亚型的标志物和治疗手段至关重要。

研究设计与样本

  • 在MLL重排急性髓系白血病模型中,针对已知H3K4甲基化修饰因子进行CRISPR覆盖筛选。

主要发现

  • 破坏SETD1B催化SET结构域导致FLT3-ITD或NrasG12D表达的白血病细胞耗竭。
  • SETD1B SET结构域缺失导致基因表达下调,尤其在MYC通路。
  • SETD1B SET结构域缺失导致H3K4me3宽度显著降低。
  • 外源性MYC表达或破坏H3K4去甲基化酶KDM5C可显著恢复SETD1B SET结构域突变细胞的生长缺陷。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Histone H3 lysine 4 trimethylation (H3K4me3) is abundant in mixed-lineage leukemia-rearranged (MLL-r) acute myeloid leukemia (AML) cells; however, the responsible enzymes and their roles remain unclear. This study aimed to identify the modifier responsible for high H3K4me3 modification in MLL-r leukemia and its downstream targets essential for the cell proliferation. Here, we performed a CRISPR-tiling screen against known H3K4 methylation modifiers in an MLL-r AML model. Disrupting the SETD1B catalytic SET domain caused depletion of FLT3-ITD or NrasG12D-expressing AML cells, and gene expression downregulation, particularly in the MYC pathway. SETD1B SET domain loss results in a significant decrease in H3K4me3 breadth. Exogenous MYC expression or disrupting H3K4 demethylase KDM5C significantly restored growth defects in SETD1B SET domain-mutant cells. These data indicated that SETD1B was required for H3K4me3 breadth and MYC expression. Thus, a thorough understanding of SETD1B-mediated H3K4me3 breadth is critical for developing markers and therapies for MYC-dependent leukemia subtypes.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Izumi S, Ohtani K, Matsumoto M, et al. Regulation of H3K4me3 breadth and MYC expression by the SETD1B catalytic domain in MLL-rearranged leukemia. Leukemia. 2025. PMID: 40341256. doi:10.1038/s41375-025-02638-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。